Puberty, Precocious Clinical Trial
Official title:
An Open-label, Non-Comparative Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Faslodex (Fulvestrant) in Girls With Progressive Precocious Puberty Associated With McCune-Albright Syndrome
The purpose of this study is to evaluate the safety, effectiveness and pharmacokinetics of a study drug called Faslodex (fulvestrant) in the treatment of progressive precocious puberty (PPP) (early puberty) in girls with McCune-Albright syndrome (MAS)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05957991 -
Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty
|
||
Completed |
NCT04012632 -
Kisspeptin/GPR54 Pathway and Early Puberty
|
||
Completed |
NCT00094328 -
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
|
Phase 2 | |
Completed |
NCT02431416 -
Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty
|
N/A | |
Recruiting |
NCT06083415 -
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context
|
N/A | |
Not yet recruiting |
NCT06263868 -
First Observatory of Precocious Puberty.
|
||
Completed |
NCT00635817 -
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
|
Phase 3 | |
Completed |
NCT00494169 -
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
|
||
Completed |
NCT00660010 -
Study of Lupron Depot In The Treatment of Central Precocious Puberty
|
Phase 3 | |
Recruiting |
NCT04884620 -
The 3rd COPENHAGEN Puberty Study
|
||
Active, not recruiting |
NCT03628937 -
The Effect of Decaffeinated Green Tea Polyphenol Intake on the Risk of Precocious Puberty Among Obese Girls
|
N/A | |
Enrolling by invitation |
NCT02790112 -
Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
|
N/A |